OFD Biopharma, LLC

Form 483 issued July 1, 2022 · Albany, Oregon

Inspection
Jun 27 – Jul 1, 2022
Observations
3
Pages
5
FEI number
3022538

In short: On July 1, 2022, FDA issued a Form 483 with 3 observations to OFD Biopharma, LLC in Albany, Oregon (FEI 3022538) after an inspection that ran Jun 27 – Jul 1, 2022. The investigators were Rowena S. Nguyen and Sara H. Gabel. Most observations concern laboratory controls and quality system.

At a glance

Laboratory controls and quality system account for 2 of 3 observations.

Laboratory controls1
Quality system1
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Laboratory controls do not include the establishment of scientifically sound and appropriate standards and test procedures…

  2. 02

    Written records of investigations into unexplained discrepancies do not always include…

  3. 03

    Changes to written procedures are not drafted, reviewed and approved by…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at OFD Biopharma, LLC?

FDA listed 3 observations on this Form 483, mostly about laboratory controls, quality system and production. The opening words of each observation are shown on this page.

Who inspected OFD Biopharma, LLC?

Rowena S. Nguyen and Sara H. Gabel are named on this Form 483, for the inspection of Jun 27 – Jul 1, 2022. Each investigator has a profile showing what they cite most.

When was OFD Biopharma, LLC inspected by FDA?

The inspection ran Jun 27 – Jul 1, 2022, and the Form 483 is dated July 1, 2022.

How do I get the full Form 483 for OFD Biopharma, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free